Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 9/20 | 0.43 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | PARP1 | P09874 | 2/20 | 0.43 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.43 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.41 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.41 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.41 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.41 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3256088 | 0.84 | MAPT (0.44) | CA1CA2ALDH1A1KMT2AELANE | |
| SCHEMBL29394739 | 0.84 | RAB9A (0.39) | CA1CA2ALDH1A1KMT2AELANE | |
| Acetic Acid SCHEMBL6648493 | 0.83 | NQO2 (0.44) | — | |
| SCHEMBL6914487 | 0.82 | CYP3A4 (0.39) | CA1CA2ALDH1A1ELANECA12 | |
| SCHEMBL8385557 | 0.80 | MAPT (0.39) | PARP10CA1CA2PARP15ALDH1A1 | |
| SCHEMBL19998352 | 0.79 | CYP3A4 (0.37) | PARP10CA1CA2ALDH1A1GPR119 | |
| SCHEMBL5360319 | 0.79 | MT-CO2 (0.37) | CA1CA2ELANEMAPTMT-CO2 | |
| SCHEMBL5421359 | 0.79 | RAB9A (0.43) | ALDH1A1KMT2AAAK1MAPTTSHR | |
| SCHEMBL8736767 | 0.78 | MEN1 (0.43) | ALDH1A1KMT2ACYP3A4TSHRCYP2C19 | |
| SCHEMBL6648429 | 0.77 | POLB (0.44) | ALDH1A1POLBMAPTTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552739-B2 | Method for preparing primary amide compounds from secondary or tertiary amides | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2026-02-17 | — | — | US | disclosed |
| US-20230234913-A1 | METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2023-07-27 | — | — | US | disclosed |
| US-20230234913-A1 | METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2023-07-27 | — | — | US | disclosed |
| US-20230234913-A1 | METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234913-A1 | METHOD FOR PREPARING PRIMARY AMIDE COMPOUNDS FROM SECONDARY OR TERTIARY AMIDES | CA3, NAAA, ATL3 | PARP10 2269/4885PARP4 2845/4885CA1 11/4885 |
| US-12552739-B2 | Method for preparing primary amide compounds from secondary or tertiary amides | CPS1, NAAA, MLN | PARP10 3223/4885PARP4 3132/4885CA1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.